Application of cells with high TAA (tumor associated antigen) presentation potential seems to be crucial in neoplasia immunotherapy. Such feature is distributed in dendritic cells, which present peptides from processed TAA -MHC molecules complex to the T cells of a host. the aim of the study was to assess the influence of colon neoplasia tissue lysate on functioning of generated autologous DC's in the field of autologous CD4+ lymphocytes immunological response towards Th1/Th2 under in vitro environment together with comparison and assessment of DCs' immunosuppressive properties acquired from patients with colon cancer. material and methods. The population of this study consisted of 16 healthy-controls, 36colon cancer patients. Blood samples were collected 24h before planned surgery and preventive antibiotic therapy. Neoplastic tissue sample, was digested for cell lysates preparation. DC's generation from PBMC was carried out in standard conditionsand medium enriched with rhGM-CSF and rhIL-4. Mature DC`s and cocultured autologous CD4 lymphocytes immunophenotype assessment was analyzed with flow cytometer. Intracellular and culture medium cytokines concentration was analyzed with ELISA and FACS method. Results. DC`s generated from colon cancer patients stimulated with lysates presented greater maturity, lower expression of CD206 antigen, significantly higher expression of HLA-DR, CD208 and CD209 and high intracellular expression of IL-12, compared to non-stimulated cells. Conclusions. The neoplastic tissue in vivo produces a number of substances having an unfavorable effect on immune system, our results suggests using lysates as good dendritic cells stimulators that possibly could have application in colon cancer immunotherapy.
properties play a preventive role from destruction by immune cells. Application of cells withhigh TAA (tumor associated antigen) presentation potential seems to be crucial in neoplasia immunotherapy. Such feature is distributed in dendritic cells, which present peptides from processed TAA -MHC molecules complex to the T cells of a host. As a result, specific T cytotoxic (CD8+) lymphocytes are activated.
Recent studies on the immune system, especially involving T regulatory cells and Th17 lymphocytes, shed new light on the process of dendritic cells antigen presentation (1) (2) (3) (4) . It seems that mentioned cells modulate the action of DC's (dendritic cells). Thus, in order to increase both, specificity and efficacy of immunotherapy, a method which would use the interaction of T regulatory cells, Th17 and dendritic cells, followed by presentation of antigen to cytotoxic cells capable of neoplastic cells extinction, should be devised.
The aim of the study was to assess the influence of colon neoplasia tissue lysate on functioning of generated autologousDC's in the field of autologous CD4+ lymphocytes immunological response towards Th1/Th2 under in vitro environment together with comparison and assessment of DCs' immunosuppressive properties acquired from patients with colon cancer and with free of disease blood donors, basing on phenotype study and ability of selected immunosuppressive cytokines production.
MATERIAL AND METHODS

Clinical characteristics of colon cancer patients
36 colon cancer patients treated surgically without preoperative chemotherapy were introduced to the study. Patients were hospitalized in the Medical University of Lublin I Chair and Department of General and Transplant Surgery, General Surgery Department, Cardinal Stefan Wyszyński District Specialist Hospital in Lublin; II Chair and Department of General and Gastrointestinal Surgery and Surgical Oncology of the Alimentary Tract. Patients age varied from 48 to 70 (average 59±11 years). The study group consisted of 17 females and 19 males. Samples for histopathological material for the study were obtained during the surgeries.
Characteristics of control group
16 patients were introduced to the study, from whom leukocyte-platelet supernatant was obtained. Age of the control group donors varied from 42 to 47 years (average 44.5 ± 2.5 years). 8 females and 8 males comprised the control group. All study participants showed no signs of infection, nor underwent treatment affecting the immune system and had no blood transfusion. Patients with a history of allergic diseases were excluded from the study. The study was carried out in line with the protocol accepted by theMedical University of Lublin Bioethics Committee (KE-0254/50/2010 from 25.02.2010)
Study material
Blood samples from cephalic vein were collected twenty four hours before planned surgery and preventive antibiotic therapy into filled with sodium heparin test-tubes (Polfa, Warsaw) in the amount of 20 U/ml of blood. Neoplastic tissue was placed in Ringer's solution (Polfa Lublin, Poland). Obtained solid tissue and blood were processed immediately after the withdrawal. Mononuclear cells required for control studies were obtained from healthy donors from leukocyte-platelet specimen handed over by Lublin Regional Blood Donation and Blood Treatment Center.
Mononuclear cells isolation
Whole blood was diluted in 1:1 ratio with buffered Ringer's solution -calcium-and magnesium-free phosphate-buffered saline (PBS) (Biochrome AG, Germany), piled on Gradisol L (Aqua Medica, Poland) and centrifuged at 700xg for 20 minutes in the gradient density. Obtained mononuclear cell fraction washed twice in calcium-magnesium-free PBS and centrifuged at 700xg for 5 minutes. After washing process the cells were suspended in 1 ml calcium-magnesiumfree PBS, counted in Neubauer chamber, followed by life span assessment with trypan blue staining technique (0.4% Trypan Blue Soulution, Sigma, Germany). Cells with a life span under 90% were disqualified from further procedure Magnetic separation of CD3+ cells with "Easy Sep" technique Isolated mononuclear cells of circulatory blood were suspended in calcium-magnesiumfree PBS complemented by 0.5% BSA and 2 mm EDTA in the quantity of 1x10 8 cells/ml. 100 µl/ml of antibody anti-CD3 coupled with dextrane (StemCell Technologies, USA) had been added to suspension and incubated for 15 minutes in room temperature. Subsequently, the solution was incubated with secondary antibody anti-dextran coupled with paramagnetic for 10 minutes in room temperature. After incubation period cells were placed in magnetic field and additionally incubated for 5 minutes. Negative fraction was effused, whereas positive fraction settled in test tubes. Fraction purity under 90% (assessed with flow cytometry) disqualified CD3+ lymphocytes from further studies. Amount of CD3+ cells in CD3-fraction over 10% disqualified them from further studies. Dendritic cells were generated from CD3-fraction, whereas CD3+ fraction banked until mature autologous dendritic cells were obtained.
Neoplastic cells isolation
Neoplastic tissue sample, free of necrotic area, 2 cm 3 of a size, was fragmented with a surgical scalpel. Fragmented tissue suspended in 30 ml of RPMI 1640 (PanBiotech, Germany) with additional enzymes: 1 mg/ml type I collagenase (Biochrome AG, Germany) and 1 mg/ ml type I DNase (Sigma, Germany). Commixture was placed in a 100 ml glass bottle and digested in sterile condition with a usage of magnetic stirrer (Kucharczyk, Poland) in a temperature of 37 o C for 60 minutes afterwards. Digested suspension was filtered and centrifuged at 700xg for 5 minutes. Obtained cells were washed twice in unenriched RPMI 1640, counted and divided into two groups, where group I was banked and group II was used for cell lysates preparation.
Neoplastic cell lysates preparation
Neoplastic cell lysates were prepared through a five cycle rapid freeze-rapid thaw process (-80˚C and 37˚C consecutively) of a cell solution in 1 ml RPMI 1640 phenol red-free (PanBiotech, Germany). The suspension was centrifuged at 700xg for 5 minutes, subsequently the supernatant was collected and filtered through 0.2 μm filter. First part of the filter was freezed (until adding it to the dendritic cells culture), whereas protein concentration was estimated in the second part of the filter.
Protein level estimation in neoplastic cells lysates
In order to estimate the protein level, light absorbance at 280 nm and spectrophotometer DU ® 530 (Beckman, USA) were used. Moreover, in order to minimalize the influence of nucleic acids content, additional absorbance at 260 nm was measured, whereas protein concentration was measured with a following method: protein concentration (mg/ml) = 1.5 x absorbance at 280 nm -0.75 x absorbance at 260 nm Freezing and thawing of cells Isolated cells were freezed until autologous dendritic cells were prepared. The freezing process took place in ice-bath. 10-20x106/ml of cells weresoluted in RPMI 1640 with 10% human albumin and 10% DMSO (ICN PolfaRzeszów, Poland). Subsequently, the cells were rapidly thawed in a water bath (37˚C), placed in a 10 ml test-tube, where RPMI 1640 with 10% human albumin was added every minute in a following scheme: 0.1 ml; 0.12 ml; 0.15 ml; 0.19 ml; 0.28 ml; 0.36 ml; 0.62 ml; 0.86 ml; 1.69 ml; 4.75 ml. The cells were centrifuged and suspended medium adequate to further protocol.
Immature dendritic cell generation DC's generation from circulating blood monocytes was conducted in culture bottles of 25 cm 2 area of adherence (Corning, USA), in 37˚C temperature and atmosphere of 5% CO 2. Culture medium constituted of RPMI 1640 with 2% human albumin and following antibiotics: 100 IU penicillin/ml, 50 µg streptomycin/ml, 100 µg neomycin/ml (Sigma, Germany). Separated CD3-negative fraction in amount of 5-7x10 6 /25 cm 2 suspended in 5 ml culture medium and conducted 90 minute incubation in standard conditions in order for monocytes adherence. Subsequently, nonadherent cells were washed in calcium-magnesium-free PBS. Adherent cells were cultured in 5 ml culture medium enriched with rhGM-CSF at a dosage of 1000 IU/ml (Gentaur, Belgium) and rhIL-4 at a dosage of 500 IU/ml (Gentaur, Belgia). Additionally, on the third and fifth day of the culture cytokines were added.
Stimulation of dendritic cells maturation process with lysates and irradiated neoplastic cells
On the sixth day of culture, to the bottle in which reactions of tumor cells lysates with dendritic cells were observed, prepared lysates in amount of 100 µg protein /ml culture medium were added. Into the second bottle, in which influence of irradiated tumor cells on dendritic cells maturation was studied, irradiated tumor cells in amount of 100 µg lysate protein /ml culture medium were added. In order to achieve additional induction of dendritic cells maturation, on the sixth day of culture rhTNF-α in amount of 50 ng/ml (Strathmann, Germany) was added. The cultures were harvested for 48 hours.
Culture completion
Supernatant from culture was isolated, centrifuged (for 5 min at 700xg) and kept in a -80°C temperature in order to determine the level of cytokines (IL-6, IL-10, IL-12, IFN-γ). Trypsin solution 0.25%/EDTA 0.02% in calcium-magnesium-free PBS (Biochrom AG, Germany) was poured into the bottle for 10 minutes in 37°C temperature and atmosphere of 5% CO 2 . Harvested cells were matched with supernatant cells in calcium-magnesium-free PBS and centrifuged at 700xg for 5 minutes. Subsequently, the cells were suspended in medium adequate for further studies where their lifespan was assessed. The immature DC's were collected on the sixth day of culture, whereas mature DC's on the seventh. The assessment of CD208, HLA-DR antigens and costimulatory molecules CD80, CD86 and B7-H2 was performed after 48 hour incubation of the generated dendritic cells with cancer cells lysates. Evaluating intracellular antigen CD208 of the stimulated dendritic cells, we observed that dendritic cells generated from the patients suffering from colon cancer characterized with much higher percentage of CD83-/CD208+ (p<0.01) and CD83+/ CD208+ (p<0.01) compared to the control group. Assessing CD80 and CD86 antigens on stimulated dendritic cells, it was estimated that dendritic cells generated from patients with colon cancer featured significantly higher (p<0.01) percentage of CD80+/CD86-compared to the control group. Assessing B7-H2 antigen on stimulated dendritic cells, it was observed that dendritic cells generated from patients with colon cancer characterized statistically (5) . What appears to be significant in other authors' studies is that over 40% of patients who underwent such therapy showed fundamental response of immune system (6, 7) . The source of antigen were neoplasm RNA (8) or HLA specific peptides (5, 9) subsequently processed by dendritic cells.
Evaluating the maturity degree of dendritic cells generated by patients with colon cancer, it was estimated that the percent of CD14+ cells was significantly higher after irradiated neoplastic cells stimulation. Whereas in DCs group from the healthy donors, higher percent of immature cells was observed after lysates stimulation, in the group of cells generated from the healthy donors higher expression of CD83+ antigen was showed while using radiated neoplastic cells. The percentage of cells obtained both from the healthy donors by Fig. 3 (13) on the stimulation of the DCs of patients suffering from colon cancer stimulated with lysates from culture line Colo320, SW480 and SW620 are consistent with the observations of our own. These authors indicated that the DCs stimulation with the above-mentioned lysates causes the DCs maturation and expression of CD1a, CD83 and CD86 markers in a significantly higher percentage in comparison to the control group. Additionally, in our studies we estimated the percentage of autologous CD4 lymphocytes incubated with dendritic cells stimulated with neoplastic cells' antigens. Intracellular ability to produce cytokines determining the immune response type was established. These cytokines were IL-2, IL-4, IL-10 and IFN-γ. In the conducted research the percentage of immature DCs generated from patients suffering from colon cancer and stimulated with lysates of neoplastic cells negatively correlated with the percentage of CD4+ lymphocytes producing IL-2 and INF-γ.
In their researches, Nonaka et al., generated DCs from healthy donors and incubated them with colon cancer cell line (14). They discovered that dendritic cells adhere to the neoplastic cells with the help of DC-SIGN. This reaction has an inhibitory effect on immature DCs and stimulates the dendritic cells to produce IL-6 and IL-10. In our own studies we observed significantly higher percent of CD206+/CD209+ cells among patients with colon cancer in comparison with the control group with neoplastic cells lysates stimulation.
Moreover the percent of CD206+ cells generated from patients with colon cancer negatively correlated with the percentage of autologous CD4+/IL-2+ and CD4+/IFN-γ+ lymphocytes. A significant factor in immunotherapy is the use of proper source of antigen. It can be expected that DCs' stimulation used by Chen et al. in their studies (lysates of colon cancer line cells) is the essence ofa strongerinteraction betweenthe antigen presented via DCs and cytotoxic lymphocytes against neoplastic cells. In our research we used autologous neoplastic cells which in course of neoplasm expansion developed specific mechanisme scape from the control of the immune system.
Kichler-Lakoma et al. studies, who yet again confirmed that autologous dendritic cells generated from patients with neoplasm can induce tolerance (15). DCs generated by authors had much lower expression of CD80, CD83 and CD86 antigens and weaker ability to stimulate autologous lymphocytes compared to DC`s generated from healthy donors. Kichler-Lakoma et al. studies were not conducted among patients with advanced cancer, but among the group of woman in the early stages of breast cancer (15). The poor immunogenicity of colon cancer was also confirmed with Remmel et al. studies, who stated that dendritic cells cultured with colon cancer line cells have low CD80 and CD86 expression with high HLA-DR expression (16). Our studies confirm these results. DCs generated from patients with colon cancer, stimulated with irradiated colon cancer cells, characterized with significantly lower CD80+/CD86+ percentage and higher CD80 antigen expression in comparison with control group. The use of lysates caused the increase of double positive cells percentage. The attempts of immunosuppression made by Hunyadi et al. (17) with the use of autologous neoplastic cells lysates, despite the high percentage of CD86+ (which is in agreement with our results), prove this therapy to be well tolerated by patients.
The mature dendritic cells present the antigens by creating an immunological synapse. A Signac from MHC-antigen complex and costimulatory molecules activates a lymphocyte. The additional lymphocyte activation takes place due to cytokine secretion. The dendritic cells produce cytokines determining the type of immune response: IL-10 and IL-12. In presented study the intracellular expression of IL-12 in stimulated DCs was measured. The dendritic cells generated from patients with colon cancer had significantly higher percentage of IL-12+ cells compared to cells generated from healthy donors. These observations remain in agreement with Ghanekar et al. studies, who also observed higher expression of IL-12 in cells generated from patients with cancer (18) . No statistical differences in the concentration of the above-mentioned cytokines between patients' groups and control or comparing different DCs' stimulants were observed. Pellagatta et al. (19) also observed high expression of IL-12 in immunotherapy with the use of DC`s stimulated with autologous glioblastoma cells lysates, which fully coincides with our data.
On the basis of our research results we can draw an assumption that dendritic cells generated from the patients and from the healthy donors that underwent lysates stimulation activate autologous T lymphocytes in Th1 immune response direction.
Galea-Lauri et al. suggest that the immunophenotype of mature DCs was independent from lysates or apoptotic neoplastic cells stimulation and has no influence on the immune response type (20) . Lesterhuis et al. used vaccines of autologous mature dendritic cells in immunotherapy of patients with colon cancer (21). This condition guaranteed, among authors, the induction of specific immune response (increase of T lymphocytes and lymphocytes producing INF-γ and IL-2 percentage). However, in our studies the immunophenotype of mature dendritic cells was dependent on the type of stimulation. Using lysates as a source of antigen, the higher percentage of lymphocytes with IL-2 and INF-γ expression was observed among patients suffering from cancers compared to the control group. This may indicate the existence in the organism of the patients some immune response inhibitory agents.
Summing up the previous considerations, we can conclude that the generated immature dendritic cells did not significantly differin the groups of patients and healthy control. The analysis of the immunophenotype of the stimulated dendritic cells showed differences in maturation markers expression, costimulatory molecules, secretion of IL-12 and MHC components. It is obvious the neoplastic tissue
